Holen Sie sich die Stockscreener-App
2.50
6.38%
0.15
Handel nachbörslich:
2.45
-0.05
-2.00%
Schlusskurs vom Vortag:
$2.35
Offen:
$2.35
24-Stunden-Volumen:
2.25M
Relative Volume:
1.44
Marktkapitalisierung:
$132.86M
Einnahmen:
$832.00K
Nettoeinkommen (Verlust:
$-135.12M
KGV:
-0.4105
EPS:
-6.09
Netto-Cashflow:
$-124.69M
1W Leistung:
+0.40%
1M Leistung:
+2.88%
6M Leistung:
+30.21%
1J Leistung:
-54.13%
1-Tages-Spanne:
$2.29
$2.50
1-Wochen-Bereich:
$2.29
$2.675
52-Wochen-Spanne:
$1.30
$5.80
Inovio Pharmaceuticals Inc Stock (INO) Company Profile
Firmenname
Inovio Pharmaceuticals Inc
Sektor
Branche
Telefon
(858) 410-3134
Adresse
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
Vergleichen Sie INO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INO
Inovio Pharmaceuticals Inc
|
2.50 | 124.89M | 832.00K | -135.12M | -124.69M | -6.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-09 | Eingeleitet | Piper Sandler | Overweight |
| 2024-05-14 | Eingeleitet | Stephens | Overweight |
| 2024-01-25 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2022-11-09 | Herabstufung | Maxim Group | Buy → Hold |
| 2022-11-01 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-19 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2022-05-11 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-01-21 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2021-12-29 | Fortgesetzt | Jefferies | Hold |
| 2021-09-10 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-06-24 | Eingeleitet | Jefferies | Hold |
| 2021-03-23 | Eingeleitet | BofA Securities | Neutral |
| 2021-02-12 | Eingeleitet | Oppenheimer | Outperform |
| 2020-11-17 | Herabstufung | ROTH Capital | Neutral → Sell |
| 2020-11-10 | Hochstufung | ROTH Capital | Sell → Neutral |
| 2020-09-28 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-09-28 | Hochstufung | Maxim Group | Hold → Buy |
| 2020-07-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2020-07-01 | Herabstufung | ROTH Capital | Neutral → Sell |
| 2020-06-29 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-06-26 | Herabstufung | Stifel | Buy → Hold |
| 2020-05-21 | Eingeleitet | The Benchmark Company | Buy |
| 2020-04-30 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2020-03-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-03-13 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-12-19 | Eingeleitet | ROTH Capital | Buy |
| 2018-02-15 | Bestätigt | Maxim Group | Buy |
| 2017-10-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2017-09-06 | Eingeleitet | Citigroup | Buy |
| 2017-06-08 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2017-05-24 | Bestätigt | Maxim Group | Buy |
| 2017-03-16 | Hochstufung | Maxim Group | Hold → Buy |
| 2017-03-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
Alle ansehen
Inovio Pharmaceuticals Inc Aktie (INO) Neueste Nachrichten
INOVIO to Present at Stephens Virtual Biotechnology Conference on November 4 - MyChesCo
How to read the order book for Inovio Pharmaceuticals Inc.Market Sentiment Summary & Smart Investment Allocation Tips - newser.com
What RSI levels show for Inovio Pharmaceuticals Inc. (GBM) stockMarket Rally & Weekly Stock Performance Updates - newser.com
Analyzing Inovio Pharmaceuticals Inc. with multi timeframe chartsWeekly Risk Report & Daily Chart Pattern Signals - newser.com
Why Inovio Pharmaceuticals Inc. stock is a value investor pickAnalyst Downgrade & Safe Swing Trade Setup Alerts - newser.com
Is Inovio Pharmaceuticals Inc. trending in predictive chart modelsJuly 2025 Macro Moves & High Accuracy Investment Signals - newser.com
Can Inovio Pharmaceuticals Inc. stock outperform in 2025 bull market2025 Market Outlook & Weekly High Conviction Ideas - newser.com
Can Inovio Pharmaceuticals Inc. (GBM) stock expand revenue streams2025 Buyback Activity & Long Hold Capital Preservation Tips - newser.com
Inovio (INO) Finalizes BLA Submission for INO-3107 - GuruFocus
Is Inovio Pharmaceuticals Inc. (GBM) stock a fit for income portfoliosLong Setup & AI Enhanced Trade Execution Alerts - newser.com
Statistical indicators supporting Inovio Pharmaceuticals Inc.’s strengthShare Buyback & Growth Focused Stock Reports - newser.com
Strategies to average down on Inovio Pharmaceuticals Inc.Bull Run & Technical Entry and Exit Alerts - newser.com
Can Inovio Pharmaceuticals Inc. (GBM) stock surprise markets with earningsExit Point & Momentum Based Trading Ideas - newser.com
INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults - PR Newswire
Will Inovio Pharmaceuticals Inc. stock go up soonJuly 2025 Fed Impact & Weekly High Return Opportunities - newser.com
Why hedge funds are buying Inovio Pharmaceuticals Inc. stock2025 Major Catalysts & Verified Momentum Stock Alerts - newser.com
How to use a screener to detect Inovio Pharmaceuticals Inc. breakoutsTrade Analysis Summary & Capital Efficiency Focused Strategies - newser.com
Is Inovio Pharmaceuticals Inc. stock attractive after correctionRecession Risk & Weekly High Return Forecasts - newser.com
Will breakout in Inovio Pharmaceuticals Inc. lead to full recovery2025 Dividend Review & Growth-Oriented Investment Plans - newser.com
Published on: 2025-11-03 04:28:05 - newser.com
Price momentum metrics for Inovio Pharmaceuticals Inc. explainedBull Run & Capital Efficient Trading Techniques - newser.com
Will Inovio Pharmaceuticals Inc. stock rally after Fed decisionsQuarterly Trade Summary & Verified Entry Point Signals - newser.com
What momentum indicators show for Inovio Pharmaceuticals Inc. stock2025 Key Lessons & Safe Capital Allocation Plans - newser.com
Chart based analysis of Inovio Pharmaceuticals Inc. trendsM&A Rumor & Growth Oriented Trade Recommendations - newser.com
How risky is Inovio Pharmaceuticals Inc. stock nowJuly 2025 Action & Stepwise Trade Signal Implementation - newser.com
How reliable is Inovio Pharmaceuticals Inc. (GBM) stock dividend growthGap Up & Weekly High Conviction Ideas - newser.com
What hedge fund moves indicate for Inovio Pharmaceuticals Inc. (GBM) stock2025 Performance Recap & AI Forecast Swing Trade Picks - newser.com
Can Inovio Pharmaceuticals Inc. (GBM) stock reach $200 price targetGold Moves & AI Forecast Swing Trade Picks - newser.com
Published on: 2025-11-02 13:43:13 - newser.com
Published on: 2025-11-02 06:09:53 - newser.com
Why Inovio Pharmaceuticals Inc. stock appeals to dividend seekers2025 AllTime Highs & Reliable Intraday Trade Alerts - newser.com
Inovio Pharmaceuticals Q3 Earnings Tops Estimates, Lifts Retail Sentiment - MSN
Inovio Pharmaceuticals, Inc. (INO) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Published on: 2025-11-01 12:25:46 - newser.com
INOVIO’s DNA-Encoded Antibody Trial Shows Durable In Vivo Expression - MyChesCo
Finanzdaten der Inovio Pharmaceuticals Inc-Aktie (INO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):